Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of four new Droplet Digital™ PCR (ddPCR™) ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) a global leader in life science research and clinical diagnostics products, today announced a collaboration agreement with Oncocyte Corporation (Nasdaq ...
In the first study 1, clinicians in Wuhan, China observed that a subset of infected individuals who tested negative for COVID-19 using qPCR tested positive using ddPCR. The findings suggest that ddPCR ...
Digital Droplet PCR (ddPCR) is a method for performing digital PCR use microfluidic water-oil emulsion technology. By utilizing microfluidics and fractionating DNA samples into nanoliter droplets , ...
The QX Continuum Droplet Digital™ PCR (ddPCR™) System* combines a simple workflow with sensitivity and precision, empowering researchers to explore a wide range of applications. From detecting subtle ...
Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, today announced the launch of its first ultrasensitive multiplexed digital PCR assay, the ddPLEX ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announced today that the company’s management will host an informational ...
Ultra-rapid digital droplet PCR can measure the levels of tumor cells in a tissue sample in about 15 minutes. (HealthDay News) — Intraoperative ultra-rapid droplet digital polymerase chain reaction ...
Researchers have found that the clinical application of BCR::ABL1 digital PCR can reliably quantify stable deep molecular remission of chronic myeloid leukemia (CML), which will help to determine for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback